Anti-inflammatory effects of macrolide antibiotics in the treatment of chronic rhinosinusitis

Otolaryngologic Clinics of North America

Volumn 38, Issue 6, 2005, Pages 1339-1350

  Cervin, Anders ^a   Wallwork, Ben ^b,c  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b GRIFFITH UNIVERSITY   (Australia)

^c PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN; DEXAMETHASONE; ERYTHROMYCIN; JOSAMYCIN; MACROLIDE; MIDECAMYCIN; PREDNISOLONE; ROXITHROMYCIN; STEROID;

ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; APOPTOSIS; BRONCHIOLITIS; CELL ADHESION; CHRONIC SINUSITIS; CILIARY DYSKINESIA; CLINICAL TRIAL; CYSTIC FIBROSIS; DOSE RESPONSE; DRUG ABSORPTION; DRUG ACCUMULATION; DRUG COST; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG TISSUE LEVEL; DRUG UPTAKE; HEADACHE; HUMAN; LOW DRUG DOSE; MUCOCILIARY CLEARANCE; NONHUMAN; NOSE POLYP; QUALITY OF LIFE; RESPIRATORY BURST; REVIEW; RHINOSINUSITIS; SIDE EFFECT;

ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; CHRONIC DISEASE; HUMANS; IMMUNOLOGIC FACTORS; MACROLIDES; NASAL CAVITY; PARANASAL SINUSES; RHINITIS; SINUSITIS;

EID: 28444467019     PISSN: 00306665     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otc.2005.08.002     Document Type: Review

References (44)

1. J.M. McGuire, R. Bunch, and R.C. Anderson "Ilotycin" an new antibiotic Antibiot Chemother 2 6 1952 281 283
2. S. Kudoh, H. Kimura, and T. Uetake Clinical effect of low-dose, long-term macrolide antibiotic chemotherapy on diffuse panbronchiolitis Jpn J Thorac Dis 22 1984 254
3. S. Kikuchi, H. Susaki, and A. Aoki Clinical effect of long-term low-dose erythromycin therapy for chronic sinusitis [in Japanese with English abstract] Pract Otlo (Koyoto) 84 1991 41 47
4. G.E. Stein, and D.H. Havlichek The new macrolide antibiotics. Azithromycin and clarithromycin Postgrad Med 92 1 1992 269 272 277-82
5. L.E. Bermudez, C. Inderlied, and L.S. Young Stimulation with cytokines enhances penetration of azithromycin into human macrophages Antimicrob Agents Chemother 35 12 1991 2625 2629
6. Y. Hirakata, M. Kaku, and R. Mizukane Potential effects of erythromycin on host defense systems and virulence of Pseudomonas aeruginosa Antimicrob Agents Chemother 36 9 1992 1922 1927
7. D.J. Wozniak, and R. Keyser Effects of subinhibitory concentrations of macrolide antibiotics on Pseudomonas aeruginosa Chest 125 2 Suppl 2004 62S 69S
8. H. Suzuki, A. Shimomura, and K. Ikeda Inhibitory effect of macrolides on interleukin-8 secretion from cultured human nasal epithelial cells Laryngoscope 107 12 Pt 1 1997 1661 1666
9. K. Oishi, F. Sonoda, and S. Kobayashi Role of interleukin-8 (IL-8) and an inhibitory effect of erythromycin on IL-8 release in the airways of patients with chronic airway diseases Infect Immun 62 10 1994 4145 4152
10. H. Suzuki, Y. Asada, and K. Ikeda Inhibitory effect of erythromycin on interleukin-8 secretion from exudative cells in the nasal discharge of patients with chronic sinusitis Laryngoscope 109 3 1999 407 410
11. B. Wallwork, W. Coman, and F. Feron Clarithromycin and prednisolone inhibit cytokine production in chronic rhinosinusitis Laryngoscope 112 10 2002 1827 1830
12. K. Inamura, N. Ohta, and S. Fukase The effects of erythromycin on human peripheral neutrophil apoptosis Rhinology 38 3 2000 124 129
13. K. Aoshiba, A. Nagai, and K. Konno Erythromycin shortens neutrophil survival by accelerating apoptosis Antimicrob Agents Chemother 39 4 1995 872 877
14. W.L. Hand, D.L. Hand, and N.L. King-Thompson Antibiotic inhibition of the respiratory burst response in human polymorphonuclear leukocytes Antimicrob Agents Chemother 34 5 1990 863 870
15. P.C. Braga, S. Maci, and M. Dal Sasso Effects of rokitamycin on phagocytosis and release of oxidant radicals of human polymorphonuclear leukocytes Chemotherapy 43 3 1997 190 197
16. H.C. Lin, C.H. Wang, and C.Y. Liu Erythromycin inhibits beta2-integrins (CD11b/CD18) expression, interleukin-8 release and intracellular oxidative metabolism in neutrophils Respir Med 94 7 2000 654 660
17. N. Matsuoka, K. Eguchi, and A. Kawakami Inhibitory effect of clarithromycin on costimulatory molecule expression and cytokine production by synovial fibroblast-like cells Clin Exp Immunol 104 3 1996 501 508
18. T. Miyanohara, M. Ushikai, and S. Matsune Effects of clarithromycin on cultured human nasal epithelial cells and fibroblasts Laryngoscope 110 1 2000 126 131
19. M. Desaki, H. Takizawa, and T. Ohtoshi Erythromycin suppresses nuclear factor-kappaB and activator protein-1 activation in human bronchial epithelial cells Biochem Biophys Res Commun 267 1 2000 124 128
20. B. Wallwork, W. Coman, and A. Mackay-Sim Effect of clarithromycin on nuclear factor-kappa B and transforming growth factor-beta in chronic rhinosinusitis Laryngoscope 114 2 2004 286 290
21. T. Nakano, Y. Ohashi, and A. Tanaka Roxythromycin reinforces epithelial defence function in rabbit trachea Acta Otolaryngol Suppl 538 1998 233 238
22. J. Tamaoki, K. Takeyama, and I. Yamawaki Lipopolysaccharide-induced goblet cell hypersecretion in the guinea pig trachea: inhibition by macrolides Am J Physiol 272 1 Pt 1 1997 L15 L19
23. C.S. Rhee, Y. Majima, and S. Arima Effects of clarithromycin on rheological properties of nasal mucus in patients with chronic sinusitis Ann Otol Rhinol Laryngol 109 5 2000 484 487
24. Hamid Q, Cameron L, MacLeod C, et al. Anti-inflammatory activity of clarithromycin in the treatment of adults with chronically-inflamed sinus mucosa. In: Abstracts of the European Congress of Chemotherapy; 2000; Madrid.
25. K. Nishi, M. Mizuguchi, and H. Tachibana Effect of clarithromycin on symptoms and mucociliary transport in patients with sino-bronchial syndrome [English abstract] Nippon Kyobu Shikkan Gakkai Zasshi 33 12 1995 1392 1400
26. S. Kudoh, A. Azuma, and M. Yamamoto Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin Am J Respir Crit Care Med 157 6 Pt 1 1998 1829 1832
27. A. Equi, I.M. Balfour-Lynn, and A. Bush Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial Lancet 360 9338 2002 978 984
28. A.L. Pukhalsky, G.V. Shmarina, and N.I. Kapranov Anti-inflammatory and immunomodulating effects of clarithromycin in patients with cystic fibrosis lung disease Mediators Inflamm 13 2 2004 111 117
29. L. Saiman, B.C. Marshall, and N. Mayer-Hamblett Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial JAMA 290 13 2003 1749 1756
30. J. Wolter, S. Seeney, and S. Bell Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial Thorax 57 3 2002 212 216
31. P.N. Black, F. Blasi, and C.R. Jenkins Trial of roxithromycin in subjects with asthma and serological evidence of infection with Chlamydia pneumoniae Am J Respir Crit Care Med 164 4 2001 536 541
32. E. Kostadima, S. Tsiodras, and E.I. Alexopoulos Clarithromycin reduces the severity of bronchial hyperresponsiveness in patients with asthma Eur Respir J 23 5 2004 714 717
33. M. Kraft, G.H. Cassell, and J. Pak Mycoplasma pneumoniae and Chlamydia pneumoniae in asthma: effect of clarithromycin Chest 121 6 2002 1782 1788
34. T. Shoji, S. Yoshida, and H. Sakamoto Anti-inflammatory effect of roxithromycin in patients with aspirin-intolerant asthma Clin Exp Allergy 29 7 1999 950 956
35. M. Hashiba, and S. Baba Efficacy of long-term administration of clarithromycin in the treatment of intractable chronic sinusitis Acta Otolaryngol Suppl (Stockh) 525 1996 73 78
36. A. Cervin, O. Kalm, and P. Sandkull One-year low-dose erythromycin treatment of persistent chronic sinusitis after sinus surgery: clinical outcome and effects on mucociliary parameters and nasal nitric oxide Otolaryngol Head Neck Surg 126 5 2002 481 489
37. H. Moriyama, K. Yanagi, and N. Ohtori Evaluation of endoscopic sinus surgery for chronic sinusitis: post-operative erythromycin therapy Rhinology 33 3 1995 166 170
38. T. Yamada, S. Fujieda, and S. Mori Macrolide treatment decreased the size of nasal polyps and IL-8 levels in nasal lavage Am J Rhinol 14 3 2000 143 148
39. K. Ichimura, Y. Shimazaki, and T. Ishibashi Effect of new macrolide roxithromycin upon nasal polyps associated with chronic sinusitis Auris Nasus Larynx 23 1996 48 56
40. B.K. Rubin, H. Druce, and O.E. Ramirez Effect of clarithromycin on nasal mucus properties in healthy subjects and in patients with purulent rhinitis Am J Respir Crit Care Med 155 6 1997 2018 2023
41. S.M. Ragab, V.J. Lund, and G. Scadding Evaluation of the medical and surgical treatment of chronic rhinosinusitis: a prospective, randomised, controlled trial Laryngoscope 114 5 2004 923 930
42. C.M. MacLeod, Q.A. Hamid, and L. Cameron Anti-inflammatory activity of clarithromycin in adults with chronically inflamed sinus mucosa Adv Ther 18 2 2001 75 82
43. H. Suzuki, A. Shimomura, and K. Ikeda Effects of long-term low-dose macrolide administration on neutrophil recruitment and IL-8 in the nasal discharge of chronic sinusitis patients Tohoku J Exp Med 182 2 1997 115 124
44. H. Suzuki, K. Ikeda, and R. Honma Prognostic factors of chronic rhinosinusitis under long-term low-dose macrolide therapy ORL J Otorhinolaryngol Relat Spec 62 3 2000 121 127